125 related articles for article (PubMed ID: 24220699)
1. A common variant at 8q24.21 is associated with renal cell cancer.
Gudmundsson J; Sulem P; Gudbjartsson DF; Masson G; Petursdottir V; Hardarson S; Gudjonsson SA; Johannsdottir H; Helgadottir HT; Stacey SN; Magnusson OT; Helgason H; Panadero A; van der Zanden LF; Aben KK; Vermeulen SH; Oosterwijk E; Kong A; Mayordomo JI; Sverrisdottir A; Jonsson E; Gudbjartsson T; Einarsson GV; Kiemeney LA; Thorsteinsdottir U; Rafnar T; Stefansson K
Nat Commun; 2013; 4():2776. PubMed ID: 24220699
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of DNA repair genes are associated with renal cell carcinoma.
Hirata H; Hinoda Y; Matsuyama H; Tanaka Y; Okayama N; Suehiro Y; Zhao H; Urakami S; Kawamoto K; Kawakami T; Igawa M; Naito K; Dahiya R
Biochem Biophys Res Commun; 2006 Apr; 342(4):1058-62. PubMed ID: 16510122
[TBL] [Abstract][Full Text] [Related]
3. The role of functional polymorphisms of cyclooxygenase 2 in renal cell carcinoma.
Chang WS; Liao CH; Miao CE; Wu HC; Hou LL; Hsiao CL; Ji HX; Tsai CW; Bau DT
Anticancer Res; 2014 Oct; 34(10):5481-6. PubMed ID: 25275044
[TBL] [Abstract][Full Text] [Related]
4. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
5. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
6. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of catechol-O-methyltransferase in men with renal cell cancer.
Tanaka Y; Hirata H; Chen Z; Kikuno N; Kawamoto K; Majid S; Tokizane T; Urakami S; Shiina H; Nakajima K; Dhir R; Dahiya R
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):92-7. PubMed ID: 17220335
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
[TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
10. Family history and risk of renal cell carcinoma.
Gago-Dominguez M; Yuan JM; Castelao JE; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1001-4. PubMed ID: 11535554
[TBL] [Abstract][Full Text] [Related]
11. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study.
Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492
[TBL] [Abstract][Full Text] [Related]
12. Association of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinoma.
Ajaz S; Khaliq S; Abid A; Hassan AS; Hashmi A; Sultan G; Mohsin R; Mubarrak M; Naqvi SA; Rizvi SA; Mehdi SQ
Genet Test Mol Biomarkers; 2011 Sep; 15(9):653-7. PubMed ID: 21491998
[TBL] [Abstract][Full Text] [Related]
13. Association of caveolin-1 genotypes with renal cell carcinoma risk in Taiwan.
Chang WS; Tsai CW; Wang SM; Wang SW; Wu HC; Ji HX; Lin CH; Wang ZH; Chou JC; Bau DT; Wang PS
Chin J Physiol; 2014 Aug; 57(4):220-6. PubMed ID: 25246063
[TBL] [Abstract][Full Text] [Related]
14. Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinoma.
Audenet F; Cancel-Tassin G; Bigot P; Audouin M; Gaffory C; Ondet V; Thibault F; Auribault K; Gazut S; Benhabiles N; Azzouzi AR; Méjean A; Rouprêt M; Cussenot O
J Urol; 2014 Feb; 191(2):487-92. PubMed ID: 23911636
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma.
Safarinejad MR
BJU Int; 2011 Sep; 108(5):762-70. PubMed ID: 21314884
[TBL] [Abstract][Full Text] [Related]
16. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
Shu X; Gu J; Huang M; Tannir NM; Matin SF; Karam JA; Wood CG; Wu X; Ye Y
Carcinogenesis; 2018 May; 39(6):752-757. PubMed ID: 29635281
[TBL] [Abstract][Full Text] [Related]
17. Sex specific associations in genome wide association analysis of renal cell carcinoma.
Laskar RS; Muller DC; Li P; Machiela MJ; Ye Y; Gaborieau V; Foll M; Hofmann JN; Colli L; Sampson JN; Wang Z; Bacq-Daian D; Boland A; Abedi-Ardekani B; Durand G; Le Calvez-Kelm F; Robinot N; Blanche H; Prokhortchouk E; Skryabin KG; Burdett L; Yeager M; Radojevic-Skodric S; Savic S; Foretova L; Holcatova I; Janout V; Mates D; Rascu S; Mukeria A; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Świątkowska B; Benhamou S; Cancel-Tassin G; Cussenot O; Trichopoulou A; Riboli E; Overvad K; Panico S; Ljungberg B; Sitaram RT; Giles GG; Milne RL; Severi G; Bruinsma F; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Beane Freeman LE; Koutros S; Albanes D; Männistö S; Weinstein S; Clark PE; Edwards TL; Lipworth L; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Michael Gaziano J; Sesso HD; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Teh BT; Peters U; White E; Anderson GL; Johnson L; Luo J; Chow WH; Moore LE; Choueiri TK; Wood C; Johansson M; McKay JD; Brown KM; Rothman N; Lathrop MG; Deleuze JF; Wu X; Brennan P; Chanock SJ; Purdue MP; Scelo G
Eur J Hum Genet; 2019 Oct; 27(10):1589-1598. PubMed ID: 31231134
[TBL] [Abstract][Full Text] [Related]
18. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
Machiela MJ; Hofmann JN; Carreras-Torres R; Brown KM; Johansson M; Wang Z; Foll M; Li P; Rothman N; Savage SA; Gaborieau V; McKay JD; Ye Y; Henrion M; Bruinsma F; Jordan S; Severi G; Hveem K; Vatten LJ; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Freeman LEB; Koutros S; Albanes D; Mannisto S; Weinstein S; Clark PE; Edwards TE; Lipworth L; Gapstur SM; Stevens VL; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Gaziano JM; Sesso HS; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Colli LM; Sampson JN; Besse C; Blanche H; Boland A; Burdette L; Prokhortchouk E; Skryabin KG; Yeager M; Mijuskovic M; Ognjanovic M; Foretova L; Holcatova I; Janout V; Mates D; Mukeriya A; Rascu S; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Szeszenia-Dabrowska N; Benhamou S; Cancel-Tassin G; Cussenot O; Bueno-de-Mesquita HB; Canzian F; Duell EJ; Ljungberg B; Sitaram RT; Peters U; White E; Anderson GL; Johnson L; Luo J; Buring J; Lee IM; Chow WH; Moore LE; Wood C; Eisen T; Larkin J; Choueiri TK; Lathrop GM; Teh BT; Deleuze JF; Wu X; Houlston RS; Brennan P; Chanock SJ; Scelo G; Purdue MP
Eur Urol; 2017 Nov; 72(5):747-754. PubMed ID: 28797570
[TBL] [Abstract][Full Text] [Related]
19. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer.
Cozar JM; Romero JM; Aptsiauri N; Vazquez F; Vilchez JR; Tallada M; Garrido F; Ruiz-Cabello F
Hum Immunol; 2007 Aug; 68(8):698-704. PubMed ID: 17678726
[TBL] [Abstract][Full Text] [Related]
20. A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma.
Cai H; Sun L; Cui L; Cao Q; Qin C; Zhang G; Mao X; Wang M; Zhang Z; Shao P; Yin C
Urol Int; 2013; 91(2):206-12. PubMed ID: 23295440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
